Dr. Brenda J Ernst, MD
Claim this profileMayo Clinic in Arizona
Studies Ovarian Cancer
Studies Skin Cancer
3 reported clinical trials
4 drugs studied
Area of expertise
1Ovarian Cancer
MUC1 positive
Stage IV
Stage III
2Skin Cancer
MUC1 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Brenda J Ernst, MD is currently running
MUC1-Activated T Cells
for Ovarian Cancer
This phase I trial tests the safety, side effects, best dose of MUC1-activated T cells in treating patients with ovarian cancer that has come back after a period of improvement (relapsed) or that remains despite treatment (resistant). T cells are infection fighting blood cells that can kill tumor cells. The T cells given in this study will come from the patient and are made in a laboratory to recognize MUC1, a protein on the surface of tumor cells that plays a key role in tumor cell growth. These MUC1-activated T cells may help the body's immune system identify and kill MUC1 expressing ovarian tumor cells.
Recruiting1 award Phase 18 criteria
TPIV100 + Sargramostim
for Breast Cancer
This trial tests a vaccine and a drug in patients with a specific type of breast cancer who still have cancer after chemotherapy. The vaccine helps the immune system target cancer cells, and the drug boosts white blood cells to strengthen this response. The goal is to see if this combination can better treat these patients.
Recruiting0 awards Phase 238 criteria
More about Brenda J Ernst, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Brenda J Ernst, MD has experience with
- Autologous MUC1-activated T-cells
- Multi-epitope HER2 Peptide Vaccine TPIV100
- Sargramostim
- LYL797
Breakdown of trials Brenda J Ernst, MD has run
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brenda J Ernst, MD specialize in?
Brenda J Ernst, MD focuses on Ovarian Cancer and Skin Cancer. In particular, much of their work with Ovarian Cancer has involved MUC1 positive patients, or patients who are Stage IV.
Is Brenda J Ernst, MD currently recruiting for clinical trials?
Yes, Brenda J Ernst, MD is currently recruiting for 2 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Brenda J Ernst, MD has studied deeply?
Yes, Brenda J Ernst, MD has studied treatments such as Autologous MUC1-activated T-cells, Multi-epitope HER2 Peptide Vaccine TPIV100, Sargramostim.
What is the best way to schedule an appointment with Brenda J Ernst, MD?
Apply for one of the trials that Brenda J Ernst, MD is conducting.
What is the office address of Brenda J Ernst, MD?
The office of Brenda J Ernst, MD is located at: Mayo Clinic in Arizona, Scottsdale, Arizona 85259 United States. This is the address for their practice at the Mayo Clinic in Arizona.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.